MedPath

KOVALTRY

KOVALTRY

Approved
DIN Number

02451476

Drug Class

Human

Market Date

Jul 6, 2016

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02451476
AIG Number0124180002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD02 COAGULATION FACTOR VIII
Product Specifications
Dosage FormKit ,  Powder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

ANTIHEMOPHILIC FACTOR (RECOMBINANT)Active
Strength: 1000 UNIT / VIAL
Monograph: ANTIHEMOPHILIC FACTOR (RECOMBINANT)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.